Shuai Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shuai Wu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Genxi Li
Nanjing University
6 shared publications - Yongmei Yin
Department of Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China
3 shared publications Jinlong Li
Department of Laboratory Medicine, the Second Hospital of Nanjing , Nanjing University of Chinese Medicine , Nanjing 210003 , P. R. China
2 shared publicationsYiwei Han
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, P. R. China
2 shared publicationsYue Huang
Department of Food Science and Engineering, College of Light Industry and Food Engineering , Nanjing Forestry University , Nanjing 210037 , P. R. China
2 shared publicationsZhaowei Sun
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, P. R. China
2 shared publications
Latest Publications
- 14 November 2026
- Published by American Chemical Society (ACS) in ACS Sensors
CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer
The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presence of manganese ions (Mn2+), which preferentially cleaves single-stranded DNA efficiently. Mechanistically, kinetic analyses reveal that AsCas12a exhibits a significantly higher binding affinity for Mn2+ than for magnesium ion (Mg2+), while molecular dynamics simulations suggest that Mn2+ coordination induces conformational changes to expose the RuvC endonuclease domain. Harnessing this unique property, an enzymatic cascade-amplified electrochemical biosensor integrating manganese nanoflowers is reported for the diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. By equipping screen-printed gold electrodes with DNA reporters, this diagnostic tool enables high-precision HER2 quantification and successfully distinguishes various HER2-related cell lines. Furthermore, the biosensor has been extended to analyze HER2-positive exosomes, facilitating the dynamic tracking of serum exosome levels in tumor-bearing nude mice to evaluate therapeutic efficacy and accurately distinguish HER2-positive breast cancer patients in clinical samples. This RNA-free Cas12a system may provide new insights into CRISPR-based non-nucleic acid detection, emerging as a powerful tool for dynamic tumor monitoring and precision oncology.
- 14 November 2026
- Published by American Chemical Society (ACS) in ACS Sensors
CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer
The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presence of manganese ions (Mn2+), which preferentially cleaves single-stranded DNA efficiently. Mechanistically, kinetic analyses reveal that AsCas12a exhibits a significantly higher binding affinity for Mn2+ than for magnesium ion (Mg2+), while molecular dynamics simulations suggest that Mn2+ coordination induces conformational changes to expose the RuvC endonuclease domain. Harnessing this unique property, an enzymatic cascade-amplified electrochemical biosensor integrating manganese nanoflowers is reported for the diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. By equipping screen-printed gold electrodes with DNA reporters, this diagnostic tool enables high-precision HER2 quantification and successfully distinguishes various HER2-related cell lines. Furthermore, the biosensor has been extended to analyze HER2-positive exosomes, facilitating the dynamic tracking of serum exosome levels in tumor-bearing nude mice to evaluate therapeutic efficacy and accurately distinguish HER2-positive breast cancer patients in clinical samples. This RNA-free Cas12a system may provide new insights into CRISPR-based non-nucleic acid detection, emerging as a powerful tool for dynamic tumor monitoring and precision oncology.
- 30 July 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (31) , 36919-36925
Co-assembly of Peptides and Carbon Nanodots: Sensitive Analysis of Transglutaminase 2
The structures assembled by peptides have attracted great attention due to their unique physicochemical properties. Moreover, the co-assembly of peptides with additional components can endow the structures with extended functions. In this work, we have explored the co-assembly of peptides and carbon nanodots (CNDs) by taking advantage of their non-covalent binding; thus, the obtained structure may show both the recognition capability of peptides and the catalytic activity of CNDs. Therefore, we have further used the assembled structure for the sensitive analysis of transglutaminase 2 with a low detection limit of 0.25 pg/mL. By simply replacing the peptide sequences or the nanomaterials, the strategy proposed in this work can be developed as a universal model to build the co-assemblies of peptides and nanomaterials, thus leading to their broader applications in biological and biomedical research.
- 30 July 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 13 (31) , 36919-36925
Co-assembly of Peptides and Carbon Nanodots: Sensitive Analysis of Transglutaminase 2
The structures assembled by peptides have attracted great attention due to their unique physicochemical properties. Moreover, the co-assembly of peptides with additional components can endow the structures with extended functions. In this work, we have explored the co-assembly of peptides and carbon nanodots (CNDs) by taking advantage of their non-covalent binding; thus, the obtained structure may show both the recognition capability of peptides and the catalytic activity of CNDs. Therefore, we have further used the assembled structure for the sensitive analysis of transglutaminase 2 with a low detection limit of 0.25 pg/mL. By simply replacing the peptide sequences or the nanomaterials, the strategy proposed in this work can be developed as a universal model to build the co-assemblies of peptides and nanomaterials, thus leading to their broader applications in biological and biomedical research.
- 6 February 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (5) , 3819-3826
An Electrochemical Biosensor Designed by Using Zr-Based Metal–Organic Frameworks for the Detection of Glioblastoma-Derived Exosomes with Practical Application
Glioblastoma (GBM) is one of the most fatal tumors in the brain, and its early diagnosis remains technically challenging due to the complex repertoires of oncogenic alterations and blood-brain barrier (BBB). GBM-derived specific exosomes can cross the BBB and circulate in body fluids, so they can be noninvasive biomarkers for the early diagnosis of GBM. Herein, we propose a sensitive and label-free electrochemical biosensor designed by using Zr-based Metal-Organic Frameworks (Zr-MOFs) for the detection of GBM-derived exosomes with practical application. In the design, a peptide ligand can specifically bind with human epidermal growth factor receptor (EGFR) and EGFR variant (v) III mutation (EGFRvIII), which are overexpressed on the GBM-derived exosomes. Meanwhile, Zr-MOFs encapsulated with methylene blue can absorb on the surface of the exosomes due to the interaction between Zr4+ and the intrinsic phosphate groups outside of exosomes. Consequently, the concentration of exosomes can be directly quantified by monitoring the electroactive molecules inside MOFs, ranging from 9.5 × 103 to 1.9 × 107 particles/μL with the detection of limit of 7.83 × 103 particles/μL. Furthermore, this proposed biosensor can distinguish GBM patients from healthy groups, demonstrating the great prospect for early clinical diagnosis.
- 6 February 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (5) , 3819-3826
An Electrochemical Biosensor Designed by Using Zr-Based Metal–Organic Frameworks for the Detection of Glioblastoma-Derived Exosomes with Practical Application
Glioblastoma (GBM) is one of the most fatal tumors in the brain, and its early diagnosis remains technically challenging due to the complex repertoires of oncogenic alterations and blood-brain barrier (BBB). GBM-derived specific exosomes can cross the BBB and circulate in body fluids, so they can be noninvasive biomarkers for the early diagnosis of GBM. Herein, we propose a sensitive and label-free electrochemical biosensor designed by using Zr-based Metal-Organic Frameworks (Zr-MOFs) for the detection of GBM-derived exosomes with practical application. In the design, a peptide ligand can specifically bind with human epidermal growth factor receptor (EGFR) and EGFR variant (v) III mutation (EGFRvIII), which are overexpressed on the GBM-derived exosomes. Meanwhile, Zr-MOFs encapsulated with methylene blue can absorb on the surface of the exosomes due to the interaction between Zr4+ and the intrinsic phosphate groups outside of exosomes. Consequently, the concentration of exosomes can be directly quantified by monitoring the electroactive molecules inside MOFs, ranging from 9.5 × 103 to 1.9 × 107 particles/μL with the detection of limit of 7.83 × 103 particles/μL. Furthermore, this proposed biosensor can distinguish GBM patients from healthy groups, demonstrating the great prospect for early clinical diagnosis.
- 24 January 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (4) , 2972-2978
In Situ Reduction of Porous Copper Metal–Organic Frameworks for Three-Dimensional Catalytic Click Immunoassay
In this work, the reduced metal-organic frameworks (MOFs) that can function as a three-dimensional catalytic nanoreactor for copper-catalyzed azide-alkyne cycloaddition (CuAAC) click reaction have been fabricated for the development of immunoassay. In our design, MOFs with well-defined porosity are accessible to the substrates of CuAAC, while the substrates can diffuse in the pore channel. Moreover, the high-ordered structural alignments of MOFs are beneficial for integration of copper ions into the three-dimensional lattice. Therefore, upon exposure to reduction, the copper nodes in MOFs are transformed from CuII to CuI in situ to achieve spatiotemporal control, eliminating the primarily dissolving procedure. Furthermore, the reduced MOFs can serve as a powerful catalyst to facilitate the CuAAC click reaction, which can greatly reduce time and well improve the reaction efficiency. In addition, the proposed immunoassay shows high analytical performance for hepatitis B virus surface antigen (HBsAg) quantification in a linear range of 0.03-2.0 ng mL-1 with a detection limit down to 11.2 pg mL-1. The new immunoassay has also been challenged in detection of clinical serum sample and a good consistency can be found with the time-resolved fluorescence immunoassay (TRFIA) in clinics, signifying its promising potential in the clinical diagnosis.
- 24 January 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (4) , 2972-2978
In Situ Reduction of Porous Copper Metal–Organic Frameworks for Three-Dimensional Catalytic Click Immunoassay
In this work, the reduced metal-organic frameworks (MOFs) that can function as a three-dimensional catalytic nanoreactor for copper-catalyzed azide-alkyne cycloaddition (CuAAC) click reaction have been fabricated for the development of immunoassay. In our design, MOFs with well-defined porosity are accessible to the substrates of CuAAC, while the substrates can diffuse in the pore channel. Moreover, the high-ordered structural alignments of MOFs are beneficial for integration of copper ions into the three-dimensional lattice. Therefore, upon exposure to reduction, the copper nodes in MOFs are transformed from CuII to CuI in situ to achieve spatiotemporal control, eliminating the primarily dissolving procedure. Furthermore, the reduced MOFs can serve as a powerful catalyst to facilitate the CuAAC click reaction, which can greatly reduce time and well improve the reaction efficiency. In addition, the proposed immunoassay shows high analytical performance for hepatitis B virus surface antigen (HBsAg) quantification in a linear range of 0.03-2.0 ng mL-1 with a detection limit down to 11.2 pg mL-1. The new immunoassay has also been challenged in detection of clinical serum sample and a good consistency can be found with the time-resolved fluorescence immunoassay (TRFIA) in clinics, signifying its promising potential in the clinical diagnosis.
- 23 July 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (16) , 10772-10778
Sensor Array Fabricated with Nanoscale Metal–Organic Frameworks for the Histopathological Examination of Colon Cancer
There is still no good method for the diagnosis of colon cancer, so in this work we have presented a nanoscale metal–organic framework (NMOF)-based sensor array to effectively identify normal and pathological tissues. Moreover, this method can enable a rapid and accurate histopathological examination of colon cancer with simple and easy operation. The method is designed by making use of the different interactions between the overall intracellular proteome signatures of colonic tissues and three structurally stable NMOFs featuring characteristic surface chemistry. We have demonstrated that this sensor array can exhibit excellent performance to detect unknown specimens from low-dose tissue samples with clinically relevant specificity and accuracy. Collectively, the versatile detector array based on NMOFs offers a highly discerning and adaptive alternative for identifying colon cancer tissues, which exhibits wide-ranging prospects in medical diagnosis.
- 23 July 2019
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (16) , 10772-10778
Sensor Array Fabricated with Nanoscale Metal–Organic Frameworks for the Histopathological Examination of Colon Cancer
There is still no good method for the diagnosis of colon cancer, so in this work we have presented a nanoscale metal–organic framework (NMOF)-based sensor array to effectively identify normal and pathological tissues. Moreover, this method can enable a rapid and accurate histopathological examination of colon cancer with simple and easy operation. The method is designed by making use of the different interactions between the overall intracellular proteome signatures of colonic tissues and three structurally stable NMOFs featuring characteristic surface chemistry. We have demonstrated that this sensor array can exhibit excellent performance to detect unknown specimens from low-dose tissue samples with clinically relevant specificity and accuracy. Collectively, the versatile detector array based on NMOFs offers a highly discerning and adaptive alternative for identifying colon cancer tissues, which exhibits wide-ranging prospects in medical diagnosis.
- 27 July 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (16) , 9929-9935
Design of Metal–Organic Framework-Based Nanoprobes for Multicolor Detection of DNA Targets with Improved Sensitivity
Metal-organic frameworks (MOFs) receive more and more interests in the field of analytical chemistry for their diverse structures and multifunctionalities. In this study, we have designed and fabricated nanoscale MOFs-based nanoprobes for multicolor detection of DNA targets with improved sensitivity. To do so, MOFs-based nanoprobes, constructed by using porous MOFs as scaffold to load signal dyes and DNA hairpin structure as capping shell, have been prepared. Once introduction of target, competitive displacement reaction triggers the release of fluorophores from the MOFs’ pores. Consequently, a significantly enhanced fluorescence signal can be observed owing to the high loading capacity of MOFs. Therefore, the stimuli-responsive nanoprobes can enable sensitive detection of DNA targets with a low detection limit of 20 fM and selective identification to discriminate single-base mismatch. Moreover, the MOFs can encapsulate different fluorophores with different DNA gatekeepers designed according to the sequence of target DNA, resulting in more kinds of stimuli-responsive nanoprobes for multiplexed DNA analysis in the same solution. Furthermore, these smart nanoprobes reported in this paper may provide a unique MOF-based tool for detection of various targets via stimuli-responsive systems in the future to widen the applications of MOFs.
- 27 July 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (16) , 9929-9935
Design of Metal–Organic Framework-Based Nanoprobes for Multicolor Detection of DNA Targets with Improved Sensitivity
Metal-organic frameworks (MOFs) receive more and more interests in the field of analytical chemistry for their diverse structures and multifunctionalities. In this study, we have designed and fabricated nanoscale MOFs-based nanoprobes for multicolor detection of DNA targets with improved sensitivity. To do so, MOFs-based nanoprobes, constructed by using porous MOFs as scaffold to load signal dyes and DNA hairpin structure as capping shell, have been prepared. Once introduction of target, competitive displacement reaction triggers the release of fluorophores from the MOFs’ pores. Consequently, a significantly enhanced fluorescence signal can be observed owing to the high loading capacity of MOFs. Therefore, the stimuli-responsive nanoprobes can enable sensitive detection of DNA targets with a low detection limit of 20 fM and selective identification to discriminate single-base mismatch. Moreover, the MOFs can encapsulate different fluorophores with different DNA gatekeepers designed according to the sequence of target DNA, resulting in more kinds of stimuli-responsive nanoprobes for multiplexed DNA analysis in the same solution. Furthermore, these smart nanoprobes reported in this paper may provide a unique MOF-based tool for detection of various targets via stimuli-responsive systems in the future to widen the applications of MOFs.